CDH1 and primary effusion lymphoma: In this study, we review our experience with the challenging diagnosis of PEL in a patient with a low frequency of proerythroblasts, as well as the difficulty in meeting the current World Health Organization (WHO) diagnostic criteria for this erythroleukemia [8] and the importance of including E-cadherin as a potential diagnostic marker for PEL.